Technical Articles
SLAMF7/CRACC/CD319
Application of FITC-labeled SLAMF7/CRACC/CD319 Fc chimeric protein in the study of macrophage hyperactivation
Macrophages play an important role in defending against microbial infections, but abnormal activation of macrophage function can trigger inflammation and lead to significant histopathological changes. In atherosclerotic plaques, there are notable histopathological alterations, and abnormal activation of macrophage function is also evident in autoimmune diseases such as rheumatoid arthritis and inflammatory bowel disease.
View details
- Cell Biology
- SLAMF7/CRACC/CD319
- Macrophages
- Rheumatoid Arthritis
Application of SLAMF7/CRACC/CD319 Fc chimeric protein in the regulation of macrophage inflammation in sepsis research
Sepsis is one of the leading causes of hospital mortality, and its pathological mechanisms remain unclear. Currently, sepsis is defined as life-threatening organ dysfunction caused by a dysregulated host response to infection.
View details
- Immunity/Inflamma
- SLAMF7/CRACC/CD319
- Sepsis
- Inflammatory Regulation
FITC-Labeled SLAMF7/CRACC/CD319 Fc Chimera Protein: A Green Navigation Beacon for Immunotherapy in Multiple Myeloma
FITC-Labeled SLAMF7/CRACC/CD319 Fc Chimera Protein is a high-performance fluorescently labeled fusion protein with critical value in immunotherapy research for hematologic malignancies such as multiple myeloma.
View details
- Cancer
- SLAMF7/CRACC/CD319
- Fc Chimera
- Multiple Myeloma
- Hematologic Malignancies
- 1














